EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASE
- 11 October 2017
- journal article
- assessments
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 33 (4) , 504-520
Abstract
Objectives: Tackling ethical dilemmas faced by reimbursement decision makers requires deeper understanding of values on which health technology assessment (HTA) agencies are founded and how trade-offs are made. This was explored in this study including the case of rare disease.Methods: Representatives from eight HTA explored values on which institutions are founded using a narrative approach and reflective multicriteria (developed from EVIDEM, criteria derived from ethical imperatives of health care). Trade-offs between criteria and the impact of incorporating defined priorities (including for rare diseases) were explored through a quantitative values elicitation exercise.Results: Participants reported a diversity of substantive and procedural values with a common emphasis on scientific excellence, stakeholder involvement, independence, and transparency. Examining the ethical imperatives behind EVIDEM criteria was found to be useful to further explore substantive values. Most criteria were deemed to reflect institutions’ values, while 70 percent of the criteria were reported by at least half of participants to be considered formally by their institutions. The quantitative values elicitation highlighted the difficulty to balance imperatives of “alleviating or preventing patient suffering,” “serving the whole population equitably,” “upholding healthcare system sustainability,” and “making decisions informed by evidence and context” but may help share the ethical reasoning behind decisions. Incorporating “Priorities” (including for rare diseases) helped reveal trade-offs from other criteria and their underlying ethical imperatives.Conclusions: Reflective multicriteria are useful to explore substantive values of HTAs, reflect how these values and their ethical underpinnings can be operationalized into criteria, and explore the ethical reasoning at the heart of the healthcare debate.Keywords
This publication has 19 references indexed in Scilit:
- HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUESInternational Journal of Technology Assessment in Health Care, 2016
- Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-EffectivenessInternational Journal of Health Policy and Management, 2016
- Measuring the Value of Prescription DrugsNew England Journal of Medicine, 2015
- Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific AdaptationPharmacoEconomics, 2015
- Expanded HTA: Enhancing Fairness and LegitimacyInternational Journal of Health Policy and Management, 2015
- REVEALING AND ACKNOWLEDGING VALUE JUDGMENTS IN HEALTH TECHNOLOGY ASSESSMENTInternational Journal of Technology Assessment in Health Care, 2014
- Legitimate Healthcare Limit Setting in a Real-World Setting: Integrating Accountability for Reasonableness and Multi-Criteria Decision AnalysisPublic Health Ethics, 2014
- Social value judgments in healthcare: a philosophical critiqueJournal of Health Organization and Management, 2012
- Confronting Trade-Offs In Health Care: Harvard Pilgrim Health Care’s Organizational Ethics ProgramHealth Affairs, 2007
- Priority setting of health interventions: the need for multi-criteria decision analysisCost Effectiveness and Resource Allocation, 2006